Tony Serge Lialin - 11 Aug 2025 Form 4 Insider Report for VivoSim Labs, INC. (VIVS)

Role
Chief Commercial Officer
Signature
/s/ Norman Staskey, attorney-in-fact
Issuer symbol
VIVS
Transactions as of
11 Aug 2025
Transactions value $
$0
Form type
4
Filing time
21 Aug 2025, 20:45:18 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lialin Tony Serge Chief Commercial Officer 11555 SORRENTO VALLEY ROAD, SUITE 100, SAN DIEGO /s/ Norman Staskey, attorney-in-fact 21 Aug 2025 0002082194

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIVS Options (right to buy) Award $0 +40K $0.00 40K 11 Aug 2025 Common Stock 40K $1.78 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests over a four year period, with 25% of the total number of shares subject to the option vesting on the August 11, 2026, and the balance vesting in 12 equal quarterly installments thereafter.